 |
The Journal of Neuroscience, November 24, 2004, 24(47):10707-10715; doi:10.1523/JNEUROSCI.3502-04.2004
Previous Article | Next Article 
Cellular/Molecular
Prefrontal Cortex Stimulation Induces 2-Arachidonoyl-Glycerol-Mediated Suppression of Excitation in Dopamine Neurons
Miriam Melis,1,2 *
Simona Perra,1,2 *
Anna Lisa Muntoni,1,3
Giuliano Pillolla,1,2
Beat Lutz,4
Giovanni Marsicano,4
Vincenzo Di Marzo,5
Gian Luigi Gessa,1,2 and
Marco Pistis1,2
1Center of Excellence "Neurobiology of Addiction," 2"B. B. Brodie" Department of Neuroscience, and 3Consiglio Nazionale delle Ricerche (CNR) Institute of Neuroscience, University of Cagliari, 09042 Monserrato (CA), Italy, 4Group Molecular Genetics of Behavior, Max Planck Institute of Psychiatry, 80804 Munich, Germany, and 5CNR Endocannabinoid Research Group, Institute of Biomolecular Chemistry, 80078 Pozzuoli, Italy
Endocannabinoids form a novel class of retrograde messengers that modulate short- and long-term synaptic plasticity. Depolarization-induced suppression of excitation (DSE) and inhibition (DSI) are the best characterized transient forms of endocannabinoid-mediated synaptic modulation. Stimulation protocols consisting of long-lasting voltage steps to the postsynaptic cell are routinely used to evoke DSE-DSI. Little is known, however, about more physiological conditions under which these molecules are released in vitro. Moreover, the occurrence in vivo of such forms of endocannabinoid-mediated modulation is still controversial. Here we show that physiologically relevant patterns of synaptic activity induce a transient suppression of excitatory transmission onto dopamine neurons in vitro. Accordingly, in vivo endocannabinoids depress the increase in firing and bursting activity evoked in dopamine neurons by prefrontal cortex stimulation. This phenomenon is selectively mediated by the endocannabinoid 2-arachidonoyl-glycerol (2-AG), which activates presynaptic cannabinoid type 1 receptors. 2-AG synthesis involves activation of metabotropic glutamate receptors and Ca2+ mobilization from intracellular stores. These findings indicate that dopamine neurons release 2-AG to shape afferent activity and ultimately their own firing pattern. This novel endocannabinoid-mediated self-regulatory role of dopamine neurons may bear relevance in the pathogenesis of neuropsychiatric disorders such as schizophrenia and addiction.
Key words: CB1; dopamine; endocannabinoid; excitatory transmission; midbrain; retrograde signal
Received Aug 25, 2004;
revised October 7, 2004;
accepted October 12, 2004.
This article has been cited by other articles:

|
 |

|
 |
 
Y. Zhao, M. E. Rubio, and T. Tzounopoulos
Distinct Functional and Anatomical Architecture of the Endocannabinoid System in the Auditory Brainstem
J Neurophysiol,
May 1, 2009;
101(5):
2434 - 2446.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Antonelli, M. C. Tomasini, R. Mazza, K. Fuxe, S. Gaetani, V. Cuomo, S. Tanganelli, and L. Ferraro
Cannabinoid CB1 and Cholecystokinin CCK2 Receptors Modulate, in an Opposing Way, Electrically Evoked [3H]GABA Efflux from Rat Cerebral Cortex Cell Cultures: Possible Relevance for Cortical GABA Transmission and Anxiety
J. Pharmacol. Exp. Ther.,
May 1, 2009;
329(2):
708 - 717.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe
Endocannabinoid-Mediated Control of Synaptic Transmission
Physiol Rev,
January 1, 2009;
89(1):
309 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Marinelli, S. Pacioni, T. Bisogno, V. Di Marzo, D. A. Prince, J. R. Huguenard, and A. Bacci
The Endocannabinoid 2-Arachidonoylglycerol Is Responsible for the Slow Self-Inhibition in Neocortical Interneurons
J. Neurosci.,
December 10, 2008;
28(50):
13532 - 13541.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Zhang and C. Chen
Endocannabinoid 2-Arachidonoylglycerol Protects Neurons by Limiting COX-2 Elevation
J. Biol. Chem.,
August 15, 2008;
283(33):
22601 - 22611.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. A. Edwards, L. Zhang, and B. E. Alger
Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus
PNAS,
June 10, 2008;
105(23):
8142 - 8147.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Adermark and D. M. Lovinger
Retrograde endocannabinoid signaling at striatal synapses requires a regulated postsynaptic release step
PNAS,
December 18, 2007;
104(51):
20564 - 20569.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hashimotodani, T. Ohno-Shosaku, M. Watanabe, and M. Kano
Roles of phospholipase Cbeta and NMDA receptor in activity-dependent endocannabinoid release
J. Physiol.,
October 15, 2007;
584(2):
373 - 380.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. Oka, S. Arai, K. Waku, A. Tokumura, and T. Sugiura
Depolarization-induced Rapid Generation of 2-Arachidonoylglycerol, an Endogenous Cannabinoid Receptor Ligand, in Rat Brain Synaptosomes
J. Biochem.,
May 1, 2007;
141(5):
687 - 697.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Uchigashima, M. Narushima, M. Fukaya, I. Katona, M. Kano, and M. Watanabe
Subcellular Arrangement of Molecules for 2-Arachidonoyl-Glycerol-Mediated Retrograde Signaling and Its Physiological Contribution to Synaptic Modulation in the Striatum
J. Neurosci.,
April 4, 2007;
27(14):
3663 - 3676.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hashimotodani, T. Ohno-Shosaku, and M. Kano
Endocannabinoids and Synaptic Function in the CNS
Neuroscientist,
April 1, 2007;
13(2):
127 - 137.
[Abstract]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Straiker and K. Mackie
Metabotropic suppression of excitation in murine autaptic hippocampal neurons
J. Physiol.,
February 1, 2007;
578(3):
773 - 785.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hashimotodani, T. Ohno-Shosaku, and M. Kano
Presynaptic Monoacylglycerol Lipase Activity Determines Basal Endocannabinoid Tone and Terminates Retrograde Endocannabinoid Signaling in the Hippocampus
J. Neurosci.,
January 31, 2007;
27(5):
1211 - 1219.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Narushima, M. Uchigashima, M. Fukaya, M. Matsui, T. Manabe, K. Hashimoto, M. Watanabe, and M. Kano
Tonic Enhancement of Endocannabinoid-Mediated Retrograde Suppression of Inhibition by Cholinergic Interneuron Activity in the Striatum
J. Neurosci.,
January 17, 2007;
27(3):
496 - 506.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. H. Good
Endocannabinoid-Dependent Regulation of Feedforward Inhibition in Cerebellar Purkinje Cells
J. Neurosci.,
January 3, 2007;
27(1):
1 - 3.
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
B. Szabo, M. J. Urbanski, T. Bisogno, V. D. Marzo, A. Mendiguren, W. U. Baer, and I. Freiman
Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol
J. Physiol.,
November 15, 2006;
577(1):
263 - 280.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Bari, P. Spagnuolo, F. Fezza, S. Oddi, N. Pasquariello, A. Finazzi-Agro, and M. Maccarrone
Effect of Lipid Rafts on Cb2 Receptor Signaling and 2-Arachidonoyl-Glycerol Metabolism in Human Immune Cells
J. Immunol.,
October 15, 2006;
177(8):
4971 - 4980.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Beierlein and W. G. Regehr
Local Interneurons Regulate Synaptic Strength by Retrograde Release of Endocannabinoids
J. Neurosci.,
September 27, 2006;
26(39):
9935 - 9943.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Yoshida, M. Fukaya, M. Uchigashima, E. Miura, H. Kamiya, M. Kano, and M. Watanabe
Localization of diacylglycerol lipase-alpha around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor.
J. Neurosci.,
May 3, 2006;
26(18):
4740 - 4751.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Isokawa and B. E. Alger
Ryanodine Receptor Regulates Endogenous Cannabinoid Mobilization in the Hippocampus
J Neurophysiol,
May 1, 2006;
95(5):
3001 - 3011.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Kawamura, M. Fukaya, T. Maejima, T. Yoshida, E. Miura, M. Watanabe, T. Ohno-Shosaku, and M. Kano
The CB1 cannabinoid receptor is the major cannabinoid receptor at excitatory presynaptic sites in the hippocampus and cerebellum.
J. Neurosci.,
March 15, 2006;
26(11):
2991 - 3001.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
U. Pagotto, G. Marsicano, D. Cota, B. Lutz, and R. Pasquali
The Emerging Role of the Endocannabinoid System in Endocrine Regulation and Energy Balance
Endocr. Rev.,
February 1, 2006;
27(1):
73 - 100.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K.-M. Jung, R. Mangieri, C. Stapleton, J. Kim, D. Fegley, M. Wallace, K. Mackie, and D. Piomelli
Stimulation of Endocannabinoid Formation in Brain Slice Cultures through Activation of Group I Metabotropic Glutamate Receptors
Mol. Pharmacol.,
November 1, 2005;
68(5):
1196 - 1202.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Isokawa and B. E Alger
Retrograde endocannabinoid regulation of GABAergic inhibition in the rat dentate gyrus granule cell
J. Physiol.,
September 15, 2005;
567(3):
1001 - 1010.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
K. A. Sharkey and Q. J. Pittman
Central and Peripheral Signaling Mechanisms Involved in Endocannabinoid Regulation of Feeding: A Perspective on the Munchies
Sci. Signal.,
March 29, 2005;
2005(277):
pe15 - pe15.
[Abstract]
[Full Text]
[PDF]
|
 |
|
|

|